Back
Byrna Technologies 10K Form
Buy
64
BYRN
Byrna Technologies
Last Price:
$31.12
Seasonality Move:
13.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-04-12 | 10Q | BYRN/Byrna Technologies Quarterly |
| 2021-02-26 | 10K | BYRN/Byrna Technologies Annual |
| 2020-10-09 | 10Q | BYRN/Byrna Technologies Quarterly |
| 2020-07-20 | 10Q | BYRN/Byrna Technologies Quarterly |
| 2020-06-03 | 10Q | BYRN/Byrna Technologies Quarterly |
| 2020-05-18 | 10K | BYRN/Byrna Technologies Annual |
Receive BYRN News And Ratings
See the #1 stock for the next 7 days that we like better than BYRN
BYRN Financial Statistics
Sales & Book Value
| Annual Sales: | $42.6M |
|---|---|
| Cash Flow: | $1.4M |
| Price / Cash Flow: | 65.9 |
| Annual Sales: | $1.99 |
| Price / Book: | 14.55 |
Profitability
| EPS (TTM): | -0.13930 |
|---|---|
| Net Income (TTM): | $-2.8M |
| Gross Margin: | $23.6M |
| Return on Equity: | -6.5% |
| Return on Assets: | -5.33% |
Byrna Technologies Earnings Forecast
Key Byrna Technologies Financial Ratios
-
The Gross Profit Margin over the past 17 years for BYRN is 55.45%.
-
The Selling, General & Administrative Expenses for BYRN have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is -0.91% of Operating Income.
-
The Net Earning history of BYRN is -19.21% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 9 years.
Byrna Technologies Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | BYRN |
| Website: | byrna.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.91 |
| Quick Ratio: | 2.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 83.54 |
BYRN Technical Analysis vs Fundamental Analysis
Buy
64
Byrna Technologies (BYRN)
is a Buy
Is Byrna Technologies a Buy or a Sell?
-
Byrna Technologies stock is rated a BuyThe current Byrna Technologies [BYRN] share price is $31.14. The Score for BYRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.